Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond

N Z Med J. 2008 Feb 15;121(1269):5-10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Australia / epidemiology
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control*
  • Drug Costs
  • Health Priorities
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • New Zealand / epidemiology
  • Pravastatin / adverse effects
  • Pravastatin / economics
  • Pravastatin / therapeutic use*
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pravastatin